FPH.NZ Stock — Price, Charts & Analysis

Fisher & Paykel Healthcare Corporation Limited (FPH.NZ) has a trailing P/E of 54.34x and a forward P/E of 39.81x. This places FPH.NZ in a premium earnings multiple territory based on the valuation data currently available on Worldtickers.

FPH.NZ trades with 54.34x earnings on Worldtickers. Use valuation together with growth, balance sheet strength, and risk before deciding whether FPH.NZ looks overvalued or undervalued.

FPH.NZ's P/E of 54.34x should be judged against Healthcare peers, growth rate, margins, and balance sheet quality. A lower P/E may indicate value, while a higher P/E often means investors expect stronger future growth.

FPH.NZ's trailing EPS is NZ$0.79 and forward EPS is NZ$1.08. Reported earnings growth is 14.30%, which helps show current profit momentum.

EPS, or earnings per share, shows how much profit Fisher & Paykel Healthcare Corporation Limited generated for each share. FPH.NZ's trailing EPS is NZ$0.79, and investors usually prefer EPS that is positive and growing over time.

Fisher & Paykel Healthcare Corporation Limited has a market cap of NZ$25.21B, making FPH.NZ a large-cap stock based on the current market value shown on Worldtickers.

FPH.NZ's latest stock price on Worldtickers is NZ$42.93. The latest move is -NZ$0.02 or -0.05%. Use the live quote, chart, volume, and 52-week range to judge the current trading context.

FPH.NZ's quote includes a latest price of NZ$42.93. The market open is NZ$42.95. Previous close is NZ$42.95. The intraday range is NZ$41.60 to NZ$43.74.

FPH.NZ is down in the latest quote, with a move of -NZ$0.02 or -0.05%. To understand the reason, compare this move with news, earnings updates, analyst changes, sector performance, and market-wide direction.

FPH.NZ generated NZ$2.31B in trailing revenue. Revenue growth is 14.00%, which helps show whether demand is expanding or slowing.

FPH.NZ's revenue growth is 14.00%, which is a strong demand signal in the latest available data. Investors usually compare revenue growth with margin trends and valuation to judge whether growth is profitable.

Yes, FPH.NZ shows positive profitability metrics in the latest data available on Worldtickers. Net income to common shareholders is NZ$468.50M.

Gross margin is 63.69%. Margins show how efficiently Fisher & Paykel Healthcare Corporation Limited turns revenue into profit.

Fisher & Paykel Healthcare Corporation Limited carries NZ$146.10M and holds NZ$461.10M in cash.

FPH.NZ holds NZ$461.10M on its balance sheet.

FPH.NZ's book value per share is NZ$3.60.

Yes, Fisher & Paykel Healthcare Corporation Limited pays a dividend of NZ$0.52 per share annually. The dividend yield is 121.00%. The payout ratio is 54.22%.

FPH.NZ's dividend yield is 121.00%. Its payout ratio is 54.22%, which helps judge dividend sustainability. Dividend investors usually prefer a reasonable yield, consistent cash flow, and a payout ratio that leaves room for reinvestment.

Worldtickers does not currently show a confirmed next ex-dividend date for FPH.NZ. The page does show dividend rate and yield when available, and investors should confirm record and payment dates through Fisher & Paykel Healthcare Corporation Limited's investor relations materials.

FPH.NZ's five-year average dividend yield is 147.00%. Use this alongside current yield, payout ratio, and cash flow to understand whether today's dividend looks high or low versus recent history.

Institutions hold 38.15% of FPH.NZ shares. Insiders hold 3.65% of shares. Ownership mix helps investors understand how much of Fisher & Paykel Healthcare Corporation Limited is held by professional investors and company insiders.

FPH.NZ has 587.29M shares outstanding. Float shares are 585.02M. Share count affects market cap, EPS, ownership percentages, and the impact of buybacks or dilution.

Insider activity can be useful context for FPH.NZ, especially when multiple executives buy shares with their own money. Insider selling is harder to interpret because executives may sell for taxes, diversification, or planned compensation reasons.

Forward EPS for FPH.NZ is NZ$1.08. Earnings growth is 14.30%. Revenue growth is 14.00%. For earnings, investors usually watch EPS, revenue, margins, guidance, and management commentary.

FPH.NZ's trailing EPS is NZ$0.79. Forward EPS is NZ$1.08. Use the earnings section on the page to compare reported results, estimates, and trend changes when those datasets are available.

FPH.NZ is in the Healthcare sector. Its earnings multiple is 54.34x. Its latest displayed growth metric is 14.00%. Compare these figures with sector peers before deciding whether Fisher & Paykel Healthcare Corporation Limited is stronger or weaker than average.

FPH.NZ trades at NZ$42.93. The stock trades at 54.34x earnings. Whether to invest depends on your risk tolerance, time horizon, diversification, and view of Fisher & Paykel Healthcare Corporation Limited's fundamentals.

FPH.NZ risks include company execution, valuation, competition in Healthcare, interest rates, and broad market volatility. Beta is 0.89, which helps estimate market sensitivity. No single stock should be evaluated without portfolio context.

FPH.NZ should be compared with companies in Medical Instruments & Supplies. Its earnings multiple is 54.34x. Useful comparison points include revenue growth, margins, debt, cash flow, valuation, analyst targets, and price momentum.

Fisher & Paykel Healthcare Corporation Limited (FPH.NZ) operates in Healthcare, specifically Medical Instruments & Supplies. Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilati

FPH.NZ trades on NZSE. Exchange context matters because trading hours, liquidity, currency, and settlement rules can differ across markets.

FPH.NZ stock is priced in NZD on Worldtickers. Currency matters for international investors because exchange-rate moves can affect local-currency returns.

Fisher & Paykel Healthcare Corporation Limited's official website listed on Worldtickers is www.fphcare.com. Investor relations pages are useful for earnings releases, annual reports, filings, and shareholder presentations.

Fisher & Paykel Healthcare Corporation Limited employs about 7.36K people based on the latest company profile data available on Worldtickers. Workforce size helps investors understand company scale and operating complexity.

Fisher & Paykel Healthcare Corporation Limited is headquartered in Auckland, New Zealand. Headquarters location can matter for currency, regulation, tax, labor market, and regional economic exposure.

FPH.NZ is in the Healthcare sector and the Medical Instruments & Supplies industry. Sector context helps investors compare valuation, growth, margins, and risk against similar companies.

FPH.NZ has traded between NZ$32.16 and NZ$43.74 over the past 52 weeks. At NZ$42.93, it is 1.85% below the high and 33.49% above the low. The 52-week range helps gauge long-term price momentum.

FPH.NZ is above both its 50-day and 200-day moving averages, which is a common uptrend signal. Its 50-day moving average is NZ$40.28 and its 200-day moving average is NZ$38.07.

FPH.NZ's RSI is 62.50. Readings below 30 are commonly viewed as oversold, above 70 as overbought, and the current reading suggests a neutral momentum setup.

FPH.NZ's latest RSI reading is 62.50, which points to neutral momentum today. Traders usually confirm RSI with volume, trend, and nearby support or resistance.

Key support for FPH.NZ is near NZ$39.25. Key resistance is near NZ$43.33. Breaks above resistance or below support can change the short-term technical setup.

FPH.NZ's nearest reported support level is NZ$39.25. A clean break below support can weaken the short-term setup, while repeated bounces can show demand.

FPH.NZ's nearest reported resistance level is NZ$43.33. A breakout above resistance can improve momentum, especially when volume confirms the move.

FPH.NZ trades about 449.73K shares daily on average. The latest displayed volume is 222.02K shares. Volume helps show liquidity and whether trading interest is unusually high or low.

FPH.NZ's MACD is -0.03, which is a negative momentum reading. MACD should be reviewed with price trend, moving averages, RSI, volume, and support or resistance levels.

FPH.NZ is above both its 50-day and 200-day moving averages, which is a common uptrend signal. RSI is 62.50 (neutral). MACD is bearish. Nearest support is around NZ$39.25. Resistance is around NZ$43.33. A buy decision should also consider valuation, earnings quality, risk tolerance, and position sizing.

MA20 is NZ$41.98 (2.26% from price). MA50 is NZ$40.28 (6.59% from price). MA200 is NZ$38.07 (12.76% from price). The moving-average stack helps separate short-term momentum from long-term trend risk.

The server report currently confirms daily moving-average levels rather than a separate EMA-only value. FPH.NZ's MA20 is NZ$41.98. MA50 is NZ$40.28. For EMA-specific overlays, use the live chart indicators and compare EMA direction with RSI, MACD, volume, support, and resistance.

FPH.NZ's pivot is near NZ$42.84. Support is near NZ$39.25. Resistance is near NZ$43.33. Price holding above pivot can support a constructive setup, while rejection near resistance can cap momentum.

The next lower support zone for FPH.NZ is near NZ$41.02. These levels help define risk and possible follow-through zones after a breakout or breakdown.

FPH.NZ's Bollinger range is roughly NZ$40.25 to NZ$43.71. Band width is near 8.25%. Price near the upper band can show stretched upside momentum, while price near the lower band can show downside pressure or a possible mean-reversion zone.

FPH.NZ's ATR-based typical daily range is about 2.52%. ATR helps size risk because wider ranges usually require wider stops or smaller position sizes.

Latest volume is 222.02K shares. Average volume is about 449.73K shares. Breakouts with rising relative volume are usually more reliable than moves on light participation.

FPH.NZ's all-time high shown on Worldtickers is NZ$43.33. Its all-time low is NZ$1.18. All-time levels provide long-range context, but recent fundamentals and market conditions matter more for current decisions.

FPH.NZ has a beta of 0.89, meaning it has historically been less volatile than the broad market. Beta is useful for judging how much a stock may move during broad market swings.